#Chr	Start	End	Ref	Alt	Ref.Gene	Func.refGene	ExonicFunc.refGene	Gene.ensGene	avsnp147	AAChange.ensGene	AAChange.refGene	clinvar: Clinvar 	 CancerVar: CancerVar and Evidence 	Freq_ExAC_ALL	Freq_esp6500siv2_all	Freq_1000g2015aug_all	CADD_raw	CADD_phred	SIFT_score	GERP++_RS	phyloP46way_placental	dbscSNV_ADA_SCORE	dbscSNV_RF_SCORE	Interpro_domain	AAChange.knownGene	MetaSVM_score	Freq_ExAC_POPs	OMIM	Phenotype_MIM	OrphaNumber	Orpha	Otherinfo
12	25398281	25398281	C	T	KRAS	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs112445441	ENSG00000133703:ENST00000256078:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000311936:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000556131:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000557334:exon2:c.G38A:p.G13D;ENSG00000133703:ENST00000256078:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000311936:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000556131:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000557334:exon2:c.G38A:p.G13D	KRAS:NM_004985:exon2:c.G38A:p.G13D,KRAS:NM_033360:exon2:c.G38A:p.G13D;KRAS:NM_004985:exon2:c.G38A:p.G13D,KRAS:NM_033360:exon2:c.G38A:p.G13D	clinvar: Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.222	28.8	0.032	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G38A:p.G13D,KRAS:uc001rgq.1:exon2:c.G38A:p.G13D;KRAS:uc001rgp.1:exon2:c.G38A:p.G13D,KRAS:uc001rgq.1:exon2:c.G38A:p.G13D	0.569	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	COREAD 
12	25398281	25398281	C	T	KRAS	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000133703	rs112445441	ENSG00000133703:ENST00000256078:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000311936:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000556131:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000557334:exon2:c.G38A:p.G13D;ENSG00000133703:ENST00000256078:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000311936:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000556131:exon2:c.G38A:p.G13D,ENSG00000133703:ENST00000557334:exon2:c.G38A:p.G13D	KRAS:NM_004985:exon2:c.G38A:p.G13D,KRAS:NM_033360:exon2:c.G38A:p.G13D;KRAS:NM_004985:exon2:c.G38A:p.G13D,KRAS:NM_033360:exon2:c.G38A:p.G13D	clinvar: Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	.	.	.	6.222	28.8	0.032	5.68	12	.	.	P-loop containing nucleoside triphosphate hydrolase;Small GTP-binding protein domain	KRAS:uc001rgp.1:exon2:c.G38A:p.G13D,KRAS:uc001rgq.1:exon2:c.G38A:p.G13D;KRAS:uc001rgp.1:exon2:c.G38A:p.G13D,KRAS:uc001rgq.1:exon2:c.G38A:p.G13D	0.569	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	190070	109800;114480;137215;163200;211980;260350;601626;609942;614470;615278;	1340;268114;648;519;1333;2612;26106;227535;	1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~268114|ALPS type 4<br>ALPS type IV<br>Autoimmune lymphoproliferative syndrome type 4<br>Autoimmune lymphoproliferative syndrome type IV<br>RALD|<1 / 1 000 000|Unknown|Childhood<br>Infancy|614470 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~2612|Nevus sebaceus of Jadassohn<br>Nevus sebaceus syndrome<br>Organoid nevus syndrome<br>Schimmelpenning syndrome<br>Solomon syndrome|Unknown|Not applicable|Childhood|163200 ~26106|FDGC<br>Familial diffuse cancer of stomach<br>Familial diffuse gastric cancer<br>HDGC<br>Hereditary diffuse cancer of stomach<br>Hereditary diffuse gastric adenocarcinoma|Unknown|Autosomal dominant|Adult|137215 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	
17	7577120	7577120	C	T	TP53	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141510	rs28934576	ENSG00000141510:ENST00000509690:exon5:c.G422A:p.R141H,ENSG00000141510:ENST00000359597:exon7:c.G818A:p.R273H,ENSG00000141510:ENST00000269305:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000420246:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000445888:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000455263:exon8:c.G818A:p.R273H;ENSG00000141510:ENST00000509690:exon5:c.G422A:p.R141H,ENSG00000141510:ENST00000359597:exon7:c.G818A:p.R273H,ENSG00000141510:ENST00000269305:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000420246:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000445888:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000455263:exon8:c.G818A:p.R273H	TP53:NM_001126115:exon4:c.G422A:p.R141H,TP53:NM_001126116:exon4:c.G422A:p.R141H,TP53:NM_001126117:exon4:c.G422A:p.R141H,TP53:NM_001276697:exon4:c.G341A:p.R114H,TP53:NM_001276698:exon4:c.G341A:p.R114H,TP53:NM_001276699:exon4:c.G341A:p.R114H,TP53:NM_001126118:exon7:c.G701A:p.R234H,TP53:NM_000546:exon8:c.G818A:p.R273H,TP53:NM_001126112:exon8:c.G818A:p.R273H,TP53:NM_001126113:exon8:c.G818A:p.R273H,TP53:NM_001126114:exon8:c.G818A:p.R273H,TP53:NM_001276695:exon8:c.G701A:p.R234H,TP53:NM_001276696:exon8:c.G701A:p.R234H,TP53:NM_001276760:exon8:c.G701A:p.R234H,TP53:NM_001276761:exon8:c.G701A:p.R234H;TP53:NM_001126115:exon4:c.G422A:p.R141H,TP53:NM_001126116:exon4:c.G422A:p.R141H,TP53:NM_001126117:exon4:c.G422A:p.R141H,TP53:NM_001276697:exon4:c.G341A:p.R114H,TP53:NM_001276698:exon4:c.G341A:p.R114H,TP53:NM_001276699:exon4:c.G341A:p.R114H,TP53:NM_001126118:exon7:c.G701A:p.R234H,TP53:NM_000546:exon8:c.G818A:p.R273H,TP53:NM_001126112:exon8:c.G818A:p.R273H,TP53:NM_001126113:exon8:c.G818A:p.R273H,TP53:NM_001126114:exon8:c.G818A:p.R273H,TP53:NM_001276695:exon8:c.G701A:p.R234H,TP53:NM_001276696:exon8:c.G701A:p.R234H,TP53:NM_001276760:exon8:c.G701A:p.R234H,TP53:NM_001276761:exon8:c.G701A:p.R234H	clinvar: Likely pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	2.628e-05	.	0.000199681	5.846	27.3	0.011	4.92	17	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	TP53:uc002gii.2:exon4:c.G341A:p.R114H,TP53:uc010cnf.2:exon4:c.G341A:p.R114H,TP53:uc010cng.2:exon4:c.G341A:p.R114H,TP53:uc002gih.3:exon7:c.G818A:p.R273H,TP53:uc031qyq.1:exon7:c.G701A:p.R234H,TP53:uc002gij.3:exon8:c.G701A:p.R234H,TP53:uc002gim.3:exon8:c.G818A:p.R273H,TP53:uc010cnh.2:exon8:c.G818A:p.R273H,TP53:uc010cni.2:exon8:c.G818A:p.R273H;TP53:uc002gii.2:exon4:c.G341A:p.R114H,TP53:uc010cnf.2:exon4:c.G341A:p.R114H,TP53:uc010cng.2:exon4:c.G341A:p.R114H,TP53:uc002gih.3:exon7:c.G818A:p.R273H,TP53:uc031qyq.1:exon7:c.G701A:p.R234H,TP53:uc002gij.3:exon8:c.G701A:p.R234H,TP53:uc002gim.3:exon8:c.G818A:p.R273H,TP53:uc010cnh.2:exon8:c.G818A:p.R273H,TP53:uc010cni.2:exon8:c.G818A:p.R273H	0.939	AFR:0,AMR:0,EAS:0,FIN:0,NFE:4.746e-05,OTH:0,SAS:0	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRCA
17	7577120	7577120	C	T	TP53	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000141510	rs28934576	ENSG00000141510:ENST00000509690:exon5:c.G422A:p.R141H,ENSG00000141510:ENST00000359597:exon7:c.G818A:p.R273H,ENSG00000141510:ENST00000269305:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000420246:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000445888:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000455263:exon8:c.G818A:p.R273H;ENSG00000141510:ENST00000509690:exon5:c.G422A:p.R141H,ENSG00000141510:ENST00000359597:exon7:c.G818A:p.R273H,ENSG00000141510:ENST00000269305:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000420246:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000445888:exon8:c.G818A:p.R273H,ENSG00000141510:ENST00000455263:exon8:c.G818A:p.R273H	TP53:NM_001126115:exon4:c.G422A:p.R141H,TP53:NM_001126116:exon4:c.G422A:p.R141H,TP53:NM_001126117:exon4:c.G422A:p.R141H,TP53:NM_001276697:exon4:c.G341A:p.R114H,TP53:NM_001276698:exon4:c.G341A:p.R114H,TP53:NM_001276699:exon4:c.G341A:p.R114H,TP53:NM_001126118:exon7:c.G701A:p.R234H,TP53:NM_000546:exon8:c.G818A:p.R273H,TP53:NM_001126112:exon8:c.G818A:p.R273H,TP53:NM_001126113:exon8:c.G818A:p.R273H,TP53:NM_001126114:exon8:c.G818A:p.R273H,TP53:NM_001276695:exon8:c.G701A:p.R234H,TP53:NM_001276696:exon8:c.G701A:p.R234H,TP53:NM_001276760:exon8:c.G701A:p.R234H,TP53:NM_001276761:exon8:c.G701A:p.R234H;TP53:NM_001126115:exon4:c.G422A:p.R141H,TP53:NM_001126116:exon4:c.G422A:p.R141H,TP53:NM_001126117:exon4:c.G422A:p.R141H,TP53:NM_001276697:exon4:c.G341A:p.R114H,TP53:NM_001276698:exon4:c.G341A:p.R114H,TP53:NM_001276699:exon4:c.G341A:p.R114H,TP53:NM_001126118:exon7:c.G701A:p.R234H,TP53:NM_000546:exon8:c.G818A:p.R273H,TP53:NM_001126112:exon8:c.G818A:p.R273H,TP53:NM_001126113:exon8:c.G818A:p.R273H,TP53:NM_001126114:exon8:c.G818A:p.R273H,TP53:NM_001276695:exon8:c.G701A:p.R234H,TP53:NM_001276696:exon8:c.G701A:p.R234H,TP53:NM_001276760:exon8:c.G701A:p.R234H,TP53:NM_001276761:exon8:c.G701A:p.R234H	clinvar: Likely pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	2.628e-05	.	0.000199681	5.846	27.3	0.011	4.92	17	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	TP53:uc002gii.2:exon4:c.G341A:p.R114H,TP53:uc010cnf.2:exon4:c.G341A:p.R114H,TP53:uc010cng.2:exon4:c.G341A:p.R114H,TP53:uc002gih.3:exon7:c.G818A:p.R273H,TP53:uc031qyq.1:exon7:c.G701A:p.R234H,TP53:uc002gij.3:exon8:c.G701A:p.R234H,TP53:uc002gim.3:exon8:c.G818A:p.R273H,TP53:uc010cnh.2:exon8:c.G818A:p.R273H,TP53:uc010cni.2:exon8:c.G818A:p.R273H;TP53:uc002gii.2:exon4:c.G341A:p.R114H,TP53:uc010cnf.2:exon4:c.G341A:p.R114H,TP53:uc010cng.2:exon4:c.G341A:p.R114H,TP53:uc002gih.3:exon7:c.G818A:p.R273H,TP53:uc031qyq.1:exon7:c.G701A:p.R234H,TP53:uc002gij.3:exon8:c.G701A:p.R234H,TP53:uc002gim.3:exon8:c.G818A:p.R273H,TP53:uc010cnh.2:exon8:c.G818A:p.R273H,TP53:uc010cni.2:exon8:c.G818A:p.R273H	0.939	AFR:0,AMR:0,EAS:0,FIN:0,NFE:4.746e-05,OTH:0,SAS:0	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	
17	7577538	7577538	C	T	TP53	exonic	nonsynonymous SNV	ENSG00000141510	rs11540652	ENSG00000141510:ENST00000509690:exon4:c.G347A:p.R116Q,ENSG00000141510:ENST00000359597:exon6:c.G743A:p.R248Q,ENSG00000141510:ENST00000413465:exon6:c.G743A:p.R248Q,ENSG00000141510:ENST00000514944:exon6:c.G464A:p.R155Q,ENSG00000141510:ENST00000269305:exon7:c.G743A:p.R248Q,ENSG00000141510:ENST00000420246:exon7:c.G743A:p.R248Q,ENSG00000141510:ENST00000445888:exon7:c.G743A:p.R248Q,ENSG00000141510:ENST00000455263:exon7:c.G743A:p.R248Q	TP53:NM_001126115:exon3:c.G347A:p.R116Q,TP53:NM_001126116:exon3:c.G347A:p.R116Q,TP53:NM_001126117:exon3:c.G347A:p.R116Q,TP53:NM_001276697:exon3:c.G266A:p.R89Q,TP53:NM_001276698:exon3:c.G266A:p.R89Q,TP53:NM_001276699:exon3:c.G266A:p.R89Q,TP53:NM_001126118:exon6:c.G626A:p.R209Q,TP53:NM_000546:exon7:c.G743A:p.R248Q,TP53:NM_001126112:exon7:c.G743A:p.R248Q,TP53:NM_001126113:exon7:c.G743A:p.R248Q,TP53:NM_001126114:exon7:c.G743A:p.R248Q,TP53:NM_001276695:exon7:c.G626A:p.R209Q,TP53:NM_001276696:exon7:c.G626A:p.R209Q,TP53:NM_001276760:exon7:c.G626A:p.R209Q,TP53:NM_001276761:exon7:c.G626A:p.R209Q	clinvar: Likely pathogenic,Uncertain significance,Pathogenic|other|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 2, 2, 2, None] 	5.768e-05	7.7e-05	.	7.525	34	0.008	3.65	17	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	TP53:uc002gii.2:exon3:c.G266A:p.R89Q,TP53:uc010cnf.2:exon3:c.G266A:p.R89Q,TP53:uc010cng.2:exon3:c.G266A:p.R89Q,TP53:uc002gio.3:exon4:c.G347A:p.R116Q,TP53:uc002gig.1:exon6:c.G743A:p.R248Q,TP53:uc002gih.3:exon6:c.G743A:p.R248Q,TP53:uc002gin.3:exon6:c.G464A:p.R155Q,TP53:uc031qyq.1:exon6:c.G626A:p.R209Q,TP53:uc002gij.3:exon7:c.G626A:p.R209Q,TP53:uc002gim.3:exon7:c.G743A:p.R248Q,TP53:uc010cnh.2:exon7:c.G743A:p.R248Q,TP53:uc010cni.2:exon7:c.G743A:p.R248Q	0.960	AFR:0,AMR:0,EAS:0.0002,FIN:0,NFE:7.493e-05,OTH:0,SAS:0	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRCA
17	7577539	7577539	G	A	TP53	exonic	nonsynonymous SNV	ENSG00000141510	rs121912651	ENSG00000141510:ENST00000509690:exon4:c.C346T:p.R116W,ENSG00000141510:ENST00000359597:exon6:c.C742T:p.R248W,ENSG00000141510:ENST00000413465:exon6:c.C742T:p.R248W,ENSG00000141510:ENST00000514944:exon6:c.C463T:p.R155W,ENSG00000141510:ENST00000269305:exon7:c.C742T:p.R248W,ENSG00000141510:ENST00000420246:exon7:c.C742T:p.R248W,ENSG00000141510:ENST00000445888:exon7:c.C742T:p.R248W,ENSG00000141510:ENST00000455263:exon7:c.C742T:p.R248W	TP53:NM_001126115:exon3:c.C346T:p.R116W,TP53:NM_001126116:exon3:c.C346T:p.R116W,TP53:NM_001126117:exon3:c.C346T:p.R116W,TP53:NM_001276697:exon3:c.C265T:p.R89W,TP53:NM_001276698:exon3:c.C265T:p.R89W,TP53:NM_001276699:exon3:c.C265T:p.R89W,TP53:NM_001126118:exon6:c.C625T:p.R209W,TP53:NM_000546:exon7:c.C742T:p.R248W,TP53:NM_001126112:exon7:c.C742T:p.R248W,TP53:NM_001126113:exon7:c.C742T:p.R248W,TP53:NM_001126114:exon7:c.C742T:p.R248W,TP53:NM_001276695:exon7:c.C625T:p.R209W,TP53:NM_001276696:exon7:c.C625T:p.R209W,TP53:NM_001276760:exon7:c.C625T:p.R209W,TP53:NM_001276761:exon7:c.C625T:p.R209W	clinvar: Pathogenic|Pathogenic|other|Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	8.24e-06	.	.	7.204	34	0.003	2.56	17	.	.	p53, DNA-binding domain;p53-like transcription factor, DNA-binding;p53/RUNT-type transcription factor, DNA-binding domain	TP53:uc002gii.2:exon3:c.C265T:p.R89W,TP53:uc010cnf.2:exon3:c.C265T:p.R89W,TP53:uc010cng.2:exon3:c.C265T:p.R89W,TP53:uc002gio.3:exon4:c.C346T:p.R116W,TP53:uc002gig.1:exon6:c.C742T:p.R248W,TP53:uc002gih.3:exon6:c.C742T:p.R248W,TP53:uc002gin.3:exon6:c.C463T:p.R155W,TP53:uc031qyq.1:exon6:c.C625T:p.R209W,TP53:uc002gij.3:exon7:c.C625T:p.R209W,TP53:uc002gim.3:exon7:c.C742T:p.R248W,TP53:uc010cnh.2:exon7:c.C742T:p.R248W,TP53:uc010cni.2:exon7:c.C742T:p.R248W	0.987	AFR:0,AMR:0,EAS:0,FIN:0,NFE:1.498e-05,OTH:0,SAS:0	191170	114480;114500;114550;137800;151623;202300;259500;260350;260500;607107;614740;	150;251899;2807;1333;668;1501;524;182067;251627;251630;301;360;94;449;88673;227535;	150|-|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|161550 607107 617075 ~251899|-|1-9 / 1 000 000|Autosomal dominant|Childhood|260500 ~2807|CPP<br>Choroid plexus papilloma|-|-|All ages|260500 ~1333|Familial pancreatic cancer|1-9 / 1 000 000|Multigenic/multifactorial|Adult|260350 606856 613347 613348 614320 ~668|Osteogenic sarcoma|1-9 / 100 000|-|Childhood|259500 ~1501|-|1-9 / 1 000 000|Not applicable|Childhood|202300 ~524|-|1-9 / 100 000|Autosomal dominant|All ages|151623 609265 609266 ~182067|Glioma|1-5 / 10 000|-|-|137800 607248 613028 613029 613030 613031 613032 613033 ~251627|-|-|Not applicable|All ages|137800 616568 ~251630|-|-|Not applicable|Adult|137800 616568 ~301|-|1-9 / 100 000|-|All ages|137800 ~360|GBM<br>Glioblastoma multiforme|1-9 / 100 000|Multigenic/multifactorial<br>or&nbsp;Not applicable|All ages|137800 613029 ~94|Astrocytic tumor|1-9 / 100 000|-|All ages|137800 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~227535|Familial breast cancer<br>Familial breast carcinoma<br>Hereditary breast carcinoma|-|-|-|114480 600048 604370 605365 612555 613399 ~	BRCA
1	861390	861390	G	C	SAMD11	exonic	synonymous SNV	ENSG00000187634,ENSG00000268179	.	ENSG00000187634:ENST00000342066:exon2:c.G69C:p.P23P,ENSG00000187634:ENST00000420190:exon2:c.G69C:p.P23P,ENSG00000187634:ENST00000437963:exon2:c.G69C:p.P23P,ENSG00000268179:ENST00000598827:exon6:c.C210G:p.T70T	SAMD11:NM_152486:exon2:c.G69C:p.P23P	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 1, 0, 0, None] 	.	.	.	.	.	.	.	1	.	.	.	SAMD11:uc001abx.2:exon1:c.G69C:p.P23P,SAMD11:uc031pjl.1:exon1:c.G69C:p.P23P,SAMD11:uc031pjm.1:exon1:c.G69C:p.P23P,SAMD11:uc031pjp.1:exon1:c.G69C:p.P23P,SAMD11:uc031pjs.1:exon1:c.G69C:p.P23P,SAMD11:uc031pjt.1:exon1:c.G69C:p.P23P,SAMD11:uc031pju.1:exon1:c.G69C:p.P23P,SAMD11:uc031pjx.1:exon1:c.G69C:p.P23P,SAMD11:uc031pkc.1:exon1:c.G69C:p.P23P,SAMD11:uc031pkg.1:exon1:c.G69C:p.P23P,SAMD11:uc031pkh.1:exon1:c.G69C:p.P23P,SAMD11:uc031pki.1:exon1:c.G69C:p.P23P,SAMD11:uc031pkj.1:exon1:c.G69C:p.P23P,SAMD11:uc031pkm.1:exon1:c.G69C:p.P23P,SAMD11:uc001abv.1:exon2:c.G69C:p.P23P,SAMD11:uc001abw.1:exon2:c.G69C:p.P23P	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	616765	.	.	.	CML
1	10492	10492	C	T	NONE	intergenic	.	NONE,ENSG00000223972	rs55998931	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 1, 0, 0, None] 	.	.	.	.	.	.	.	1	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	CM 
1	10492	10492	C	T	DDX11L1	intergenic	.	NONE,ENSG00000223972	rs55998931	.	.	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[0, None, None, 0, None, None, 1, 0, 1, 0, 0, None] 	.	.	.	.	.	.	.	1	.	.	.	.	.	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	.	.	.	.	CM 
9	133748283	133748283	C	T	ABL1	exonic	nonsynonymous SNV	ENSG00000097007	rs121913459	ENSG00000097007:ENST00000318560:exon6:c.C944T:p.T315I,ENSG00000097007:ENST00000372348:exon6:c.C1001T:p.T334I	ABL1:NM_005157:exon6:c.C944T:p.T315I,ABL1:NM_007313:exon6:c.C1001T:p.T334I	clinvar: Pathogenic 	 CancerVar: Likely pathogenic EVS=[1, None, None, 1, None, None, 1, 2, 1, 2, 1, None] 	.	.	.	6.838	33	0.002	6.04	9	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain;Tyrosine-protein kinase, catalytic domain	ABL1:uc004bzv.3:exon6:c.C1001T:p.T334I,ABL1:uc004bzw.3:exon6:c.C944T:p.T315I	-0.417	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	189980	.	.	.	CML
7	140453136	140453136	A	T	BRAF	exonic	nonsynonymous SNV	ENSG00000157764	rs113488022	ENSG00000157764:ENST00000479537:exon2:c.T83A:p.V28E,ENSG00000157764:ENST00000288602:exon15:c.T1799A:p.V600E	BRAF:NM_004333:exon15:c.T1799A:p.V600E	clinvar: Pathogenic|Pathogenic,Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic|Pathogenic 	 CancerVar: Pathogenic EVS=[2, None, None, 1, None, None, 1, 2, 2, 2, 2, None] 	1.65e-05	.	.	6.642	32	0.001	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.T1799A:p.V600E	-0.768	AFR:0,AMR:8.715e-05,EAS:0,FIN:0,NFE:0,OTH:0,SAS:6.06e-05	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	CM
5	112170655	112170655	C	T	APC	exonic	nonsynonymous SNV	ENSG00000134982	.	ENSG00000134982:ENST00000504915:exon6:c.C440T:p.T147I,ENSG00000134982:ENST00000507379:exon13:c.C1697T:p.T566I,ENSG00000134982:ENST00000257430:exon15:c.C1751T:p.T584I,ENSG00000134982:ENST00000457016:exon15:c.C1751T:p.T584I,ENSG00000134982:ENST00000512211:exon15:c.C1751T:p.T584I,ENSG00000134982:ENST00000508376:exon16:c.C1751T:p.T584I	APC:NM_001127511:exon13:c.C1697T:p.T566I,APC:NM_000038:exon15:c.C1751T:p.T584I,APC:NM_001127510:exon16:c.C1751T:p.T584I	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 0, 2, 2, None] 	.	.	.	6.592	31	0.019	5.93	5	.	.	Armadillo-like helical;Armadillo-type fold	APC:uc011cvt.2:exon13:c.C1697T:p.T566I,APC:uc003kpy.4:exon15:c.C1751T:p.T584I,APC:uc003kpz.4:exon16:c.C1751T:p.T584I,APC:uc010jbz.3:exon16:c.C902T:p.T301I	0.004	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	611731	114500;114550;135290;175100;613659;	220460;247806;733;79665;99818;873;449;88673;	220460|AFAP<br>Attenuated FAP<br>Attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 608456 612591 615083 616415 ~247806|APC-related AFAP<br>APC-related attenuated FAP<br>APC-related attenuated familial polyposis coli|-|Autosomal dominant<br>or&nbsp;Autosomal recessive|-|175100 ~733|Colorectal adenomatous polyposis<br>FAP<br>Familial polyposis coli|1-9 / 100 000|Autosomal dominant<br>or&nbsp;Autosomal recessive|Adult|175100 ~79665|-|-|-|-|175100 ~99818|-|-|Autosomal dominant|All ages|175100 ~873|Aggressive fibromatosis<br>Desmoid type fibromatosis|Unknown|Not applicable<br>or&nbsp;Unknown|Adolescent<br>Adult|135290 ~449|-|1-9 / 1 000 000|Not applicable|Neonatal<br>Infancy<br>Childhood|114550 ~88673|HCC|1-5 / 10 000|Not applicable|All ages|114550 ~	GB
7	140453133	140453133	T	A	BRAF	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs397507484	ENSG00000157764:ENST00000479537:exon2:c.A86T:p.K29I,ENSG00000157764:ENST00000288602:exon15:c.A1802T:p.K601I;ENSG00000157764:ENST00000479537:exon2:c.A86T:p.K29I,ENSG00000157764:ENST00000288602:exon15:c.A1802T:p.K601I	BRAF:NM_004333:exon15:c.A1802T:p.K601I;BRAF:NM_004333:exon15:c.A1802T:p.K601I	clinvar: other,Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	7.043	33	0.0	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.A1802T:p.K601I;BRAF:uc003vwc.4:exon15:c.A1802T:p.K601I	-0.870	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	*AC2
7	140453133	140453133	T	A	BRAF	exonic;exonic	nonsynonymous SNV;nonsynonymous SNV	ENSG00000157764	rs397507484	ENSG00000157764:ENST00000479537:exon2:c.A86T:p.K29I,ENSG00000157764:ENST00000288602:exon15:c.A1802T:p.K601I;ENSG00000157764:ENST00000479537:exon2:c.A86T:p.K29I,ENSG00000157764:ENST00000288602:exon15:c.A1802T:p.K601I	BRAF:NM_004333:exon15:c.A1802T:p.K601I;BRAF:NM_004333:exon15:c.A1802T:p.K601I	clinvar: other,Pathogenic 	 CancerVar: Uncertain significance EVS=[0, None, None, 1, None, None, 1, 2, 1, 2, 2, None] 	.	.	.	7.043	33	0.0	5.65	7	.	.	Protein kinase domain;Protein kinase-like domain;Serine-threonine/tyrosine-protein kinase catalytic domain	BRAF:uc003vwc.4:exon15:c.A1802T:p.K601I;BRAF:uc003vwc.4:exon15:c.A1802T:p.K601I	-0.870	AFR:.,AMR:.,EAS:.,FIN:.,NFE:.,OTH:.,SAS:.	164757	115150;211980;613706;613707;	500;648;1340;	500|Cardiomyopathic lentiginosis<br>Familial multiple lentigines syndrome<br>LEOPARD syndrome|Unknown|Autosomal dominant|Childhood|151100 611554 613707 ~648|-|Unknown|Autosomal dominant|Neonatal|163950 605275 609942 610733 611553 613224 613706 615355 616559 616564 ~1340|CFC syndrome|Unknown|Autosomal dominant|Antenatal<br>Neonatal|115150 615278 615279 615280 ~	*A
4	55593642	55593642	T	C	KIT	exonic	nonsynonymous SNV	ENSG00000157404	rs774872724	ENSG00000157404:ENST00000288135:exon11:c.T1708C:p.Y570H,ENSG00000157404:ENST00000412167:exon11:c.T1696C:p.Y566H	KIT:NM_000222:exon11:c.T1708C:p.Y570H,KIT:NM_001093772:exon11:c.T1696C:p.Y566H	clinvar: UNK 	 CancerVar: Uncertain significance EVS=[1, None, None, 1, None, None, 1, 0, 1, 2, 2, None] 	8.248e-06	.	.	6.068	28.1	0.0	6.06	4	.	.	Protein kinase-like domain	KIT:uc010igt.2:exon1:c.T55C:p.Y19H,KIT:uc010igr.3:exon11:c.T1708C:p.Y570H,KIT:uc010igs.3:exon11:c.T1696C:p.Y566H	1.038	AFR:9.625e-05,AMR:0,EAS:0,FIN:0,NFE:0,OTH:0,SAS:0	164920	154800;172800;273300;601626;606764;	44890;519;363483;363494;363504;842;876;99865;2884;79457;98292;	44890|GIST<br>Gastrointestinal stromal sarcoma|1-5 / 10 000|Not applicable<br>or&nbsp;Autosomal dominant|Childhood<br>Adolescent<br>Adult|606764 ~519|AML<br>Acute myelogenous leukemia|1-9 / 100 000|-|All ages|601626 ~363483|Teratoma of the testis|<1 / 1 000 000|-|-|273300 ~363494|Non-dysgerminomatous germ cell tumor of testis<br>Testicular non seminomatous germ cell tumor<br>Testicular non-dysgerminomatous germ cell tumor|-|-|-|273300 ~363504|Testicular germ cell tumor|-|-|-|273300 ~842|Seminoma of testis<br>Seminomatous germ cell tumor of testis<br>Testicular seminoma|Unknown|Not applicable|Adult|273300 ~876|Endodermal sinus tumor|-|-|-|273300 ~99865|-|Unknown|Unknown|Adolescent<br>Adult|273300 ~2884|-|Unknown|Autosomal dominant|Infancy<br>Neonatal|172800 ~79457|Urticaria pigmentosa|Unknown|Not applicable|All ages|154800 ~98292|-|1-9 / 100 000|-|All ages|154800 ~	AML
